 Mesenchymal stem cells, MSCs, are promising candidates for regenerative medicine due to their ability to differentiate into various types of cells and their immunomodulatory properties. Recent research has demonstrated that MSCs can be used to treat a variety of conditions such as neurodegeneration, cardiovascular disease, diabetes and bone and cartilage disorders. However, the use of MSCs in cancer remains controversial, with some studies suggesting they could promote tumor growth while others suggest they could actively suppress it. To better understand how MSCs affect cancer progression, more research is needed to determine whether MSCs should be used in cancer therapy. This article was authored by Abdelkrim Macha, Abdelkrim Macha, Alejandro Martin Montalvo, and others.